Cited by 471Genomic variations and chromosomal abnormalitiesSchizophrenia research and treatmentGenetic Associations and Epidemiology

Disruption of the neurexin 1 gene is associated with schizophrenia

Open access
Rujescu, Dan, Ingason, Andres, Cichon, Sven, Pietiläinen, Olli P.H., Barnes, Michael R., Toulopoulou, Timothea, Picchioni, Marco, Vassos, Evangelos +45 more·2009·Human Molecular Genetics

Abstract

Deletions within the neurexin 1 gene (NRXN1; 2p16.3) are associated with autism and have also been reported in two families with schizophrenia. We examined NRXN1, and the closely related NRXN2 and NRXN3 genes, for copy number variants (CNVs) in 2977 schizophrenia patients and 33 746 controls from seven European populations (Iceland, Finland, Norway, Germany, The Netherlands, Italy and UK) using microarray data. We found 66 deletions and 5 duplications in NRXN1, including a de novo deletion: 12 deletions and 2 duplications occurred in schizophrenia cases (0.47%) compared to 49 and 3 (0.15%) in controls. There was no common breakpoint and the CNVs varied from 18 to 420 kb. No CNVs were found in NRXN2 or NRXN3. We performed a Cochran-Mantel-Haenszel exact test to estimate association between all CNVs and schizophrenia (P = 0.13; OR = 1.73; 95% CI 0.81-3.50). Because the penetrance of NRXN1 CNVs may vary according to the level of functional impact on the gene, we next restricted the association analysis to CNVs that disrupt exons (0.24% of cases and 0.015% of controls). These were significantly associated with a high odds ratio (P = 0.0027; OR 8.97, 95% CI 1.8-51.9). We conclude that NRXN1 deletions affecting exons confer risk of schizophrenia.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/hmg/ddn351

Cites

44 of 44 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Rujescu, D., Ingason, A., Cichon, S., Pietiläinen, O. P. H., Barnes, M. R., Toulopoulou, T., Picchioni, M., Vassos, E., Ettinger, U., Bramon, E., Murray, R., Ruggeri, M., Tosato, S., Bonetto, C., Steinberg, S., Sigurdsson, E., Sigmundsson, T., Petursson, H., Gylfason, A., Olason, P. I., Hardarsson, G., Jonsdottir, G. A., Gustafsson, O., Fossdal, R., Giegling, I., Möller, H.-J., Hartmann, A. M., Hoffmann, P., Crombie, C., Fraser, G., Walker, N., Lonnqvist, J., Suvisaari, J., Tuulio-Henriksson, A., Djurovic, S., Melle, I., Andreassen, O. A., Hansen, T., Werge, T., Kiemeney, L. A., Franke, B., Veltman, J., Buizer-Voskamp, J. E., GROUP Investigators, Sabatti, C., Ophoff, R. A., Rietschel, M., Nöthen, M. M., Stefansson, K., Peltonen, L., St Clair, D., Stefansson, H., & Collier, D. A.
Affiliations
  • Ludwig-Maximilians-Universität München (DE)
  • deCODE genetics, Reykjavík, Iceland
  • University of Bonn (DE)
  • Department for Molecular Medicine, National Public Health Institute, Helsinki, Finland
  • GlaxoSmithKline (United Kingdom) (GB)
  • King's College London (GB)
  • University of Verona (IT)
  • deCODE Genetics (Iceland) (IS)
  • Department of Psychiatry, National University Hospital, Reykjavík, Iceland
  • National University Hospital of Iceland (IS)
  • Department of Genomics, Life and Brain Center
  • University of Aberdeen (GB)
  • Ravenscraig Hospital, Greenock, Scotland
  • Department of Mental Health and Addiction, National Public Health Institute, Helsinki, Finland
  • Oslo University Hospital (NO)
  • Sankt Hans Hospital (DK)
  • Department of Epidemiology and Biostatistics (133 EPIB)
  • Radboud University Nijmegen (NL)
  • Rudolf Magnus Institute of Neuroscience, Department of Psychiatry
  • University of California, Los Angeles (US)
  • Division of Molecular and Clinical Neurobiology, Department of Psychiatry, Ludwig- Maximilians University, Munich, Germany
  • Broad Institute (US)
  • Department of Mental Health, University of Aberdeen, Aberdeen, Scotland
Corresponding author
Collier, David A.
Venue
Human Molecular Genetics
Published
2008-10-22
Volume
18
Issue
5
Pages
988-996
ISSN
  • 0964-6906 (ISSN-L)
  • 1460-2083
OpenAlex
W2106949460
Cited by
471
References
44
Citations by year
2026: 3 · 2025: 9 · 2024: 19 · 2023: 6 · 2022: 8 · 2021: 11 · 2020: 12 · 2019: 21 · 2018: 19 · 2017: 22 · 2016: 21 · 2015: 22 · 2014: 31 · 2013: 39 · 2012: 52
FWCI
33.24
Type
journal article
Language
en
Open access
Locations
  • Human Molecular Genetics (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • PubMed Central (acceptedVersion)
  • Lirias (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • The HKU Scholars Hub (University of Hong Kong) (submittedVersion)
  • Research Portal (King's College London) (submittedVersion, other-oa)
  • HighWire Press Open Archive (submittedVersion)
  • Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
  • VU Research Portal (submittedVersion)
  • Hirsla (Landspítali University Hospital) (submittedVersion)
Funders
  • Wellcome Trust (089061)
  • National Institute for Health and Care Research (PDA/02/06/016)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genomic variations and chromosomal abnormalities
  • Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
Keywords
schizophrenia, NRXN1, copy number variation, gene deletion, de novo deletion, genetic risk, NRXN3
MeSH terms
Adolescent, Adult, Calcium-Binding Proteins, Exons, Female, Humans, Male, Nerve Tissue Proteins, Schizophrenia, Cell Adhesion Molecules, Neuronal, Case-Control Studies, Gene Deletion, Gene Dosage, Neural Cell Adhesion Molecules, Genetic Predisposition to Disease, Gene Duplication, Gene Silencing, White People, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review